Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Mahender Yellu"'
Publikováno v:
Drug Design, Development and Therapy
Head and neck squamous cell cancer (HNSCC) is the sixth most common malignancy worldwide, and despite advances in cytotoxic, surgical and radiation techniques, outcomes are still poor in those with both locally advanced and metastatic diseases. The n
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:451-457
Despite the improvement in overall survival in patients with diffuse large B-cell lymphoma (DLBCL) in the rituximab era, the occurrence of central nervous system (CNS) relapse heralds a very poor prognosis. The evidence is conflicting on the incidenc
Publikováno v:
World Journal of Oncology
Anal cancer is a relatively rare gastrointestinal tumor with roughly 7,000 new cases per year. Metastatic anal cancer as an initial presentation occurs in 10-20% of the patients. Treatment for localized disease is well established with concurrent che
Publikováno v:
Current and Emerging Therapies in Pancreatic Cancer ISBN: 9783319582559
Pancreatic cancer is one of the leading causes of cancer death worldwide. It is currently the fourth leading cause of cancer-related deaths in both men and women in the United States and has a less than 10% 5-year survival rate for all stages combine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7eb928b4648dd884de404075b08a5353
https://doi.org/10.1007/978-3-319-58256-6_1
https://doi.org/10.1007/978-3-319-58256-6_1
Autor:
Alex Niu, Tahir Latif, Eric W. Mueller, Mahender Yellu, Anumeha Gupta, Olugbenga Olowokure, Alicia Gesenhues, LeeAnn Geraghty, Adam Lane, Lisa Grate
Publikováno v:
Journal of Clinical Oncology. 37:456-456
456 Background: The phase III MPACT trial was conducted to assess OS in patients with metastatic pancreatic adenocarcinoma (mPAC) receiving nab-paclitaxel (nab-P) 125 mg/m2 + gemcitabine (G) 1000 mg/m2 on days 1, 8, and 15 every 28 days. Due to repor
Publikováno v:
Annals of Lymphoma. 1:1-1
Background: Central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) although rare, can be devastating. Conflicting reports have been published regarding the protective effect of systemic rituximab therapy and likel
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 53(3)
Chronic myelogenous leukemia (CML) complicating pregnancy is uncommon. Literature search demonstrates only a few case reports and some case series but large studies are lacking due to its uncommon presentation. Management of these patients is particu
Publikováno v:
Hematological Oncology. 34:2-3
Neurological complications related to multiple myeloma (MM) are not uncommon; however, direct involvement of the central nervous system (CNS) is extremely rare and represents a diagnostic and therapeutic challenge. Significant survival difference has
Publikováno v:
BMJ case reports. 2013
Myelofibrosis, either primary or resulting from essential thrombocythemia or polycythemia vera, may present with highly variable white blood cell counts, including progressive leukopaenia with its associated risk of infections. Medications have been